NOVT vs RSW.L
NOVT: Novanta supplies precision motion control, optics, and specialty components to medical device, life science, and advanced industrial OEMs globally. RSW.L: A world leader in high-precision measurement, motion control, and additive manufacturing technologies serving the global industrial and healthcare sectors.
Side-by-side fundamentals
| Metric | NOVT | RSW.L | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $140.80 | £50.70 | |
| Market cap as of 2026-08-06 | $5.0B | n/a | |
| P/E as of 2026-08-06 | 104.24 | n/a | |
| Net margin as of 2026-08-06 | +5.3% | n/a | |
| Gross margin as of 2026-08-06 | +44.2% | n/a | |
| Operating margin as of 2026-08-06 | +8.9% | n/a | |
| ROE as of 2026-08-06 | +5.1% | n/a | |
| ROA as of 2026-08-06 | +3.2% | n/a | |
| Debt / equity as of 2026-08-06 | 0.19 | n/a | |
| Revenue growth (YoY) as of 2026-08-06 | +5.6% | n/a | |
| Revenue CAGR (3y) SEC XBRL | +4.4% | n/a | |
| Beta as of 2026-08-06 | 1.74 | n/a | |
| 1-year return as of 2026-07-27 close | +10.7% | +74.5% | RSW.L higher |
Fundamentals: market data, as of 2026-08-06. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.